Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Lazic R., Gabric N., Dekaris I., Bosnar D., Boban-Blagaic A., Sikiric P
If the solution looks the same as it did on day one, it is likely still good
In human clinical use, reported side effects are generally mild and transient: Mild injection site redness or discomfort (resolves within hours) Transient nausea in some patients, particularly early in the protocol Mild dizziness or light-headedness (rare, typically dose-related) Temporary fatigue in the first few days (often a sign of active tissue remodeling) No significant systemic toxicity, organ damage, hormonal suppression, or addiction potential has been documented in the published literature
Energy-expenditure and metabolic-flux research in rodent systems, probing the glucagon-receptor arm absent from single- and dual-agonist compounds
It is not FDA-approved, and this page covers research evidence rather than human-use guidance
